Stock Research: Gilead

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

Gilead

NasdaqGS:GILD US3755581036
96
  • Value
    41
  • Growth
    85
  • Safety
    Safety
    65
  • Combined
    77
  • Sentiment
    96
  • 360° View
    360° View
    96
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Gilead Sciences, Inc. is a biopharmaceutical company focused on medicines for life-threatening diseases. It operates in the biopharmaceutical industry, with marketed products including Biktarvy and others. The company operates in more than 35 countries worldwide. In the last fiscal year, the company had a market cap of $135,066 million, profits of $22,503 million, revenue of $28,754 million, and 17,600 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 96 (better than 96% compared with alternatives) for 2025, overall professional sentiment and financial characteristics for the stock Gilead are very positive. The 360° View is based on consolidating four consolidated indicators, with all but one indicator above average for Gilead. The consolidated Value Rank has an attractive rank of 65, which means that the share price of Gilead is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 65% of alternative stocks in the same industry. The consolidated Growth Rank has a good rank of 85, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth, as well as stock returns. In addition, professional market sentiment is above average compared with other stock investment alternatives with a Sentiment Rank of 96. But the company’s financing is risky with a Safety rank of 41. This means 59% of comparable companies have a safer financing structure than Gilead. ...read more

more
Index
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 21-Aug-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
65 67 n/a n/a
Growth
85 63 n/a n/a
Safety
Safety
41 70 n/a n/a
Sentiment
96 98 n/a n/a
360° View
360° View
96 96 n/a n/a
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
82 43 n/a n/a
Opinions Change
99 86 n/a n/a
Pro Holdings
n/a 94 n/a n/a
Market Pulse
60 79 n/a n/a
Sentiment
96 98 n/a n/a
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
65 67 n/a n/a
Growth
85 63 n/a n/a
Safety Safety
41 70 n/a n/a
Combined
77 86 n/a n/a
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
63 57 n/a n/a
Price vs. Earnings (P/E)
24 28 n/a n/a
Price vs. Book (P/B)
10 16 n/a n/a
Dividend Yield
92 98 n/a n/a
Value
65 67 n/a n/a
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
34 26 n/a n/a
Profit Growth
85 84 n/a n/a
Capital Growth
63 33 n/a n/a
Stock Returns
91 83 n/a n/a
Growth
85 63 n/a n/a
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
26 64 n/a n/a
Refinancing
17 24 n/a n/a
Liquidity
87 89 n/a n/a
Safety Safety
41 70 n/a n/a

Similar Stocks

Discover high‑ranked alternatives to Gilead and broaden your portfolio horizons.

Micron

NasdaqGS:MU
Country: USA
Industry: Semiconductors
Size: X-Large
Full Stock Analysis

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Alphabet

NasdaqGS:GOOG.L
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Lithia Motors

NYSE:LAD
Country: USA
Industry: Automotive Retail
Size: X-Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.